Divi’s Labs March Quarter Outcomes: Prescription drugs firm Divi’s Laboratories’ January-March 2025 led to web consolidated earnings within the quarter by 23 p.c to Rs 662 crore on an annual foundation. It was Rs 538 crore a 12 months in the past. Consolidated income from the operations elevated by 12 p.c to Rs 2585 crore from a 12 months in the past. It was Rs 2303 crore within the March 2024 quarter. The corporate has instructed the inventory markets that its whole expenditure in March 2025 was elevated to Rs 1807 crore. A 12 months in the past, the expenditure was Rs 1669 crore. Ebitda (Earnings Earlier than Curiosity, Taxes, Depreciation, and Amortization) elevated by 21.2 p.c to Rs 886 crore from a 12 months in the past. The working margin improved to 34.27 p.c. It was 31.74 p.c within the March 2024 quarter. Consolidated income from the operations of Divi’s Labs was elevated to Rs 9360 crore throughout your entire monetary 12 months 2024-25. It was Rs 7845 crore a 12 months in the past. The online consolidated revenue was Rs 2191 crore, which was Rs 1600 crore in FY 2024. The report date for the involved newsndidend has additionally really helpful the ultimate dividend of Rs 30 per share for FY 2024-25. On this, the approval of shareholders will probably be taken within the firm’s thirty fifth annual normal assembly on August 11. After this, cost will probably be made. The report date for dividend is 25 July 2025. By this date, shareholders whose names will probably be within the data of the Register of Members of the Firm or Depositors because the beneficiaries homeowners of shares will probably be entitled to dividend. For FY 2024, 2023 and 2022, the corporate additionally gave a closing dividend of Rs 30 per share. The present worth of the share of Divi’s Labs is Rs 6281.35 on BSE. The corporate had 51.89 p.c stake within the firm until the tip of March 2025. The inventory has strengthened by about 60 p.c in a 12 months. A month has seen a progress of 9 p.c. The share face worth of the inventory is Rs 2. Dividend Inventory: Dividend of ₹ 45 on every share, Might 23 is report date Disclaimer: Right here data offered right here is being offered for data. It’s obligatory to say right here that the funding market out there is topic to dangers. All the time seek the advice of specialists earlier than investing cash as an investor. There’s by no means recommendation to anybody to take a position cash on behalf of Moneycontrol.
